找回密码
 注册
搜索
查看: 1364|回复: 29

2011

[复制链接]
发表于 2010-12-22 10:16 PM | 显示全部楼层 |阅读模式


2011 analysis on everything
 楼主| 发表于 2010-12-22 10:19 PM | 显示全部楼层
回复 1# ppteam

Tech, Energy, Commodities and Gold Are Top Plays For 2011

The outlook for the U.S. stock market in the New Year figures to be an exasperating mixture of promise and peril. Positive momentum is building going into 2011, but so are dangerous bubbles.

The high-tech, energy, materials and commodities sectors will be hot in the New Year. And the U.S. stock market will get an added boost from the fact that U.S. Treasuries, municipal bonds (munis) and euro-based investments will not.

Here's what's in store for the U.S. stock market in 2011.

Three Little Rules

U.S. stock market investors who want to survive and thrive in the New Year would do well to remember three basic rules – each of them born out of the old stock-market adage that "the trend is your friend."

In 2011, the three rules U.S stock-market investors would do well to remember are:

    * The trend is your friend.
    * And if that trend has momentum, it will be your best friend.
    * But that friendship will only hold until the trend turns on you – at which point it becomes your worst enemy.

The "trend" that we're referring to here is market liquidity – and lots of it. All this liquidity is washing through the U.S. economy courtesy of the Obama stimulus package, the "quantitative-easing" strategy of the U.S. Federal Reserve, the just-enacted extension of the Bush tax cuts, a cut in payroll taxes, expanded unemployment benefits and accelerated expensing of capital investments in 2011.

A key point to understand about all this liquidity is that "more is always better sooner." And that's certainly the case here: We don't have to wait and worry about getting these simulative measures in 2011 – they're already in motion.

In this kind of market, fundamentals take a backseat (though they're not totally irrelevant). Liquidity determines the direction of stocks and other asset prices.

And there could be more liquidity to come.

The Fed's Plan For a Happy New Year
In a recent appearance on the CBS News "60 Minutes" program, U.S. Federal Reserve Chairman Ben S. Bernanke declared that the already-existing second round of quantitative easing – referred to by the market moniker of "QE2" – could very well be followed by more of the same.

That's more fuel for the stock-market fire in the New Year.

Liquidity – in all its forms, and all around the world – has been the engine of rising global prices for stocks, bonds, commodities, and even precious metals such as silver and gold.

Much of this liquidity has been stimulus-fueled. The liquidity then drives markets and asset prices higher because most of it ends up being injected into the very pipelines that supply liquidity.

Here in the U.S. market, this is all part of the Fed's "real" plan to "save" the economy. That central bank plan calls for the central bank to:

    * Liquefy the banks and all the financial intermediaries.
    * Inflate the stock market and create a "wealth effect" where people see stock prices rising and assume the economy is getting stronger.
    * Inflate commodity prices so deflationary fears don't destroy consumer spending because shoppers put off purchases, rightly reasoning that prices will be lower later.

In other words, the Fed wants to inflate everything, first by devaluing the dollar, the currency in which oil and most major commodities are priced. Then it plans to continue to devalue the dollar by printing money to make our exports cheap on world markets.

Sure, it's a "liquidity trap," and a momentum shift in the flood of liquidity is the greatest danger to rising equity prices. But as long as every crisis is met with another massive dose of liquidity, the levy will keep rising, until it eventually breaks.

Long before that happens, however, I'll have you out of all your longs and will help you start constructing strategic "shorts." In fact, I'll have all of you short everything.

That change in direction is what I mean when I refer to the prevailing trend "turning on you," and becoming your biggest enemy. That will happen when the liquidity is withdrawn.

In the meantime, there's money to be made through equity investments in different sectors and across different asset classes (courtesy of exchange-traded funds, or ETFs), by going long on positive momentum plays and by shorting some investments about to get the wind knocked out of their sails.

Let's look at some specifics.

Tapping Into Technology
The brightest stock-market star in 2011 will be tech. Right now, the hot growth areas in the world don't include the U.S. market. But that's okay: A research study of high-tech firms in the Standard & Poor's 500 Index conducted by top-tier market researcher Bespoke Investment Group found that 54% of the gross revenue recorded in 2009 was derived from international markets.

What is spectacular about tech is that technology combines global growth prospects with every company's need to improve productivity gains through advanced applicable technologies. That's everywhere. What's more, here in the U.S. market, a major corporate tax break for capital investments in technology, factories and other equipment will serve as an added tailwind to drive tech sales – and tech stocks – even higher.

U.S. companies are sitting on nearly $2 trillion in cash – their biggest hoard in 51 years. And tech firms boast some of the biggest caches of cash. As a percentage of total assets, their cash holdings are highest among all S&P 500 industry groups. Whether they use their cash to pay dividends, buy back stock, or embark on merger-and-acquisition deals – all of which we're already seeing – tech-stock investors figure to be the big beneficiaries.

There are plenty of great tech companies and slices of the tech pie. Personally, my favorite trends are cloud computing and data storage. But, maybe the easiest and broadest approach is the best. I like buying the Nasdaq Composite Index in the form of PowerShares QQQ Trust ETF (Nasdaq: QQQQ).

Put a Charge Into Your Portfolio
Energy – specifically oil, the drillers and integrated multinational giants – is poised to soar in the New Year, especially if the emerging markets stay healthy, Europe stabilizes, and the U.S. recovery hits its stride.

With a modicum of inflationary fear back in the spring and summer of 2008, oil rose to more than $145 per barrel. Given the devaluation of the U.S. dollar and rising commodity prices worldwide, crude oil is almost certain to zoom beyond its current trading range at about $85 to $89 a barrel.

The Organization of the Petroleum Exporting Countries (OPEC) has announced a target price of $90 a barrel. Given that oil was trading at $89 yesterday (Tuesday), this looks ridiculously low if demand increases as global economies recover.

ConocoPhillips (NYSE: COP) and Chevron Corp. (NYSE: CVX) are poised to rise handsomely in tandem with the price of oil. So are a few of the drillers, especially the deepwater drillers. Transocean Ltd. (NYSE: RIG), in particular, looks cheap. If the company can escape the worst of the fallout from the Gulf oil spill, it could be a big winner.

Materials, Commodities and Precious Metals Plays
The materials sector is also in good shape to benefit from a U.S. recovery and global growth. S&P 500 materials-based companies derive 45% of their revenue internationally. Rising demand in terms of growing industrial production will put upward pressure on the supply side of materials. I like keeping it simple here and play this big space by buying Materials SPDR ETF (NYSE: XLB).

Commodities investments were once the purview of the high-net-worth investor only. Today, however, every investor needs to have money invested in this crucial sector. We covered oil as part of our energy strategy (and oil, by the way, constitutes a major weighting in most commodities index funds, so be careful not to overweight your portfolio with more "black gold" than you are comfortable with).

Other key commodities groups include agriculture, minerals, livestock and metals (not including precious metals) – of which can be invested in via ETFs.

In agriculture, for example, there is the PowerShares DB Agriculture ETF (NYSE: DBA) and the MarketVectors Agribusiness ETF (NYSE: MOO).

Mostly, I like copper, cocoa, corn and cotton.

For corn, take a look at the Teucrium Corn Fund (NYSE: CORN). If you are an international investor, or have access to the London markets, the ETFS company has a series of ETFs based on the corn futures markets, including the ETFS CORN Fund (LON: CORN.LN).

With cotton, there's the iPath Dow Jones-AIG Cotton Total Return Sub-Index ETN (NYSE: BAL), which is based on the total return sub-index for cotton. It is based on the return of a single futures contract in cotton.

I also like some of the minerals and metals. There are ETFs for palladium [the ETFS Physical Palladium Fund (NYSE: PALL)] and for platinum [the ETFS Physical Platinum Shares (NYSE: PPLT) ETF]. Platinum, by the way, is a metal whose potential we've written about extensively in past issues of Money Morning.

The only caveat to loading up on commodities as we enter 2011 is that they've had a big run already and while I expect momentum to continue, there's a big wild card out there (more on that later) and I suggest either buying small and adding to positions later, or waiting until April to see if the Fed is going to keep the "QE" ship sailing at full speed.

Then there are the precious metals. I like gold, just not in over abundance. A 10% allocation to gold is never going to hurt you and it stands to be a steady winner as long as currency wars and a decimated euro bring the "store of value" discussion to Main Street investors. Money Morning has published special reports on silver and gold investing.

Playing the Downside
As I explained earlier, there is a potential downside when the trend is no longer our friend. And there's also downward momentum, which comes after upward momentum sputters.

Unless we are headed into another global meltdown or experience a devastating shock to financial markets, bonds have had their ride.

Treasury yields have backed up considerably since QE2 began. While the Fed was trying to keep interest rates low by buying Treasuries and flooding the system with liquidity, bond prices actually fell and yields rose – a lot! If the Fed is successful, or in spite of its efforts, U.S. growth gains traction and global demand for investment capital continues, rates have nowhere to go but up.

Over a trillion dollars have been invested in Treasury bonds since the fall of 2008. That safe harbor isn't going to look so safe when investors open up their fourth quarter statements and see they have losses in their bond holdings. If stocks keep rising and bond prices keep falling, there will be a capital wave out of bonds that just might upend world stability. We'll cross that bridge if we get there, but to ride the downward momentum in Treasury bonds I recommend buying ProShares Short 20+ Treasury ETF (NYSE: TBF).

Another mind-bending momentum-mayhem possibility is an exodus of investors from the municipal bond market. There's no escaping the fact that almost all U.S. states are making ends meet by means of federal handouts. County and municipal governments are almost all out of money and deep in hock.

Rising rates will be the canary in the coal mine, signaling a possible default – or, more likely, several high-profile defaults – if the Fed and the U.S. Treasury Department don't open up the spigot and keep liquidity flowing into the financial system.

If you're a muni-bond investor, think about hedging or cashing out. The timing on this one will be difficult, but it's coming. Because timing on the municipal front is so difficult, I'm not inclined to recommend what to short right now. But I will offer an update on this subject, with specific recommendations, later in 2011.

Lastly, there's the euro, the currency of the European Union. The euro has been weak lately after bouncing to heights that didn't make any sense after last summer's Greek debt woes subsided. What didn't make sense is that the euro climbed even on the heels of news about Ireland. Not until fears arose that Portugal and Spain could be next to need emergency first aid did the euro start to falter again.

The euro has nowhere to go but down. I like buying three-month-out "calls" on the ProShares UltraShort Euro ETF (NYSE: EUO). This fund is a leveraged, double-short ETF that is designed to move twice as much as the cash market for the euro currency against the dollar. That means that if the euro is falling in value relative to the dollar, EUO will rise in price.

Key Caveats
As we head into 2011 with positive momentum, there are some key warning signals that we need to watch for – since they would serve as warnings of a reversal in momentum. These warning signals include:

    * Any sovereign defaults anywhere in the world.
    * National governments or cross-government unions backing away from debt support and liquidity-supply measures.
    * Or any serious banking or financial markets crises in China.

There are plenty of reasons to be optimistic about 2011, and a few mayhem makers that can turn things upside down.

So just remember this: Your friends are only your friends until you can't trust them any more.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2010-12-22 10:21 PM | 显示全部楼层
回复 2# ppteam

Barrons Outlook 2011

While 2010 may have been a year of ambivalence and doubt–the Standard & Poor's 500 began January at 1115, then crisscrossed that line no fewer than 165 times as investors debated whether the government-engineered recovery will stick–it's ending with a clear consensus: 2011 should be a good year for stocks.

Collectively, the 10 strategists and investment managers surveyed by Barron's see the S&P 500 finishing next year near 1373, roughly 10% higher than Friday's close at 1244. But this solid if hardly extravagant target belies their increasingly expansive view of the U.S. stock market. A majority sees 2011 as the year when a sustainable economic recovery takes root, winning over skeptics and persuading both companies and consumers to relax their stranglehold on squirreled-away cash. Improving confidence and low interest rates bode well for corporate profits. Meanwhile, the Federal Reserve remains hell-bent on propping up asset prices, and wages and prices of goods aren't rising enough to sound an inflation alarm that would lead the central bank to alter its course of aggressive benevolence.

Against this backdrop, nine of the 10 strategists we polled are penciling in stock-market gains ranging from 7% to 17% for next year. That advance could be thwarted by escalating trade tensions; slowing global growth, as emerging economies tighten credit; and conflicts from Iran to the Korean peninsula. But the market has started to flinch less at each flare-up of risk.

Last spring, the escalating fiscal problems of southern Europe and Ireland triggered a broad flight from risky assets and a 15% pullback in U.S. stocks, but the second installment of European drama this November caused a mere 4% blip.

"THERE'S A GROWING SENSE that not every problem will be enough to topple the market," says Jeff Knight, head of Putnam Investments' global-asset allocation.

View Full Image
outlook_strats1
outlook_strats1
outlook_strats1

Maybe it's the passage of time from the 2008 financial crisis, and maybe it's the transfer of debt and risk from the private sector to the government, which, arguably, has more tools for managing disaster, but some of the feared perils have failed to materialize. The U.S. economy slowed at midyear, but didn't fall into a double-dip recession. Faster-growing countries from China to India began tightening credit, but haven't yet skidded to hard landings. And last week's extension of the Bush tax cuts, whether one agrees with them or not, means that our bailout tab won't have to paid just yet.

"None of the longer-term issues have been resolved: The developed world still has too much debt, wage growth is subpar, and central banks are running out of bullets to use during the next downturn," says Henry McVey, Morgan Stanley Investment Management's head of global macro and asset allocation. "But we're getting a cyclical reprieve, engineered by the central banks."

Nearly all the strategists expect stocks to outperform bonds, especially Treasuries. Even Douglas Cliggott, Credit Suisse's U.S. equity strategist, who sees the S&P 500 finishing next year almost flat—near 1250—says "You've really got to believe in outright deflation to put new money into bonds right now."

Others are even warier about bonds' prospects, with our government printing money liberally and interest rates already near historic lows. Since early November, even after the Fed detailed plans to pump $600 billion into the bond market, Treasuries have sold off violently enough to drive the yield on benchmark 10-year notes from 2.49% to 3.3%. "We've just started a secular bear market in bonds," says McVey, "and stocks are the proverbial best house in the neighborhood."

Admittedly, some of 2011's gains have been pulled forward. Stocks have rallied 19% since late August, when Fed Chairman Ben Bernanke & Co. first promised more monetary easing. Professional money managers seem quite fully invested in the short term, although that may not rule out further gains in the longer term.

It helps our consumer-driven economy that Americans are exhaling just a little. Nearly two years into our commitment to frugality, consumers have begun paying down loans, credit-card bills and other obligations with a little less urgency. Household debt has shriveled by $1 trillion recently, to $11.5 trillion. And the household-debt burden as a percentage of disposable income has eased, from 19% in 2007 to about 17%, near its 30-year average. Americans who once spent every penny now save nearly 6% of their disposable income, but the steady increase in savings has started to slow.

All these translate into more spending power–not by a lot, although it may feel like plenty after recent deprivation. We're not feeling flush, and our savings rate may never fall below a newly chaste 5%, but the slowing pace of consumer deleveraging is enough to prod the economy a bit and excite the market. In the third quarter, consumer spending grew 2.8%, the best rate since 2006, and retail, restaurant and recreation stocks levitated.

This spending uptick could have legs, if tight-fisted companies that have squeezed the most from productivity begin to hire anew. Most strategists expect the job market to thaw, if only because unemployment is already so high, at 9.8%.

"THE ECONOMY IS MOVING in a way that should cause confidence to improve, and that will affect everything from hiring to dividend payouts to consumer spending and equity-mutual-fund flows," says David Kelly, JPMorgan Funds' chief market strategist. Comments Barclays' U.S. equity strategist Barry Knapp: "We believe a bounce in business confidence is under way, and are seeing signs of increased business investment in capital and labor as a result."

Economic forecasters, of course, have a tendency to extrapolate today's conditions into the future, and, lately, the numbers are bright. Our factories are humming as manufacturing continues to expand, retail sales are rising, and optimism in even the beleaguered small-business sector has repaired to a three-year high. The private sector has added more than 1.1 million jobs in 11 months–hardly enough to replace the eight million-plus lost to the recession or to chisel away at our 10% unemployment rate, but enough to support some economic growth.

Investors aren't looking for much, anyway, and our strategists are forecasting growth of U.S. gross domestic product averaging just 3.2% next year. Since S&P 500 companies earn more than a third of their revenue abroad, and are especially hitched to commodity prices and business spending, "a V-shaped profit recovery can continue even without a V-shaped economic recovery," says David Bianco, BofA Merrill Lynch's chief U.S. equity strategist.
Companies Are Rich and Consumers Not So Poor

Corporations are hoarding a lot of cash, which, as the economy improves, could be put toward new hiring, or to buy back shares and pay dividends ...

... Americans are a long way from flush, but household debt and obligations have shrunk to levels closer to their three-decade average. As we have begun to exhale (a little), the increase in our savings rate also has started to slow.

[outlook chart 1]

Cheap borrowing costs, brutal cost-cutting during the recession, and a lingering reluctance to hire during this uncertain recovery boosted profit margins and helped S&P companies earn a weighted average of $85 a share this year–up sharply from $61 in 2009. It wouldn't take much more growth next year to surpass the previous earnings peak of $88, hit in 2006.

And yet the S&P 500 fetches 13 times what companies are projected to earn next year—a price/earnings ratio that hardly seems stretched compared with the median multiple of 16 over the past decade. Clearly, investors question whether the recovery is sustainable, and don't see an easy way out of today's risible government spending. As debt shifts from the private sector to the government, so does the onus of deleveraging. Alas, our divided and distracted Congress doesn't seem to view deficit reduction as a pressing priority.

Meanwhile, Wall Street analysts expect S&P companies to earn roughly $95 next year, and Bianco thinks this frequently mocked target is within reach, even if our economy grows just 2%. For one thing, Merrill Lynch expects that provisions set aside by banks to cover loan losses will shrink from 2.6% in 2010 to 1.8% in 2011. Sales at S&P companies also grew 10% in 2010, thanks to foreign operations, business-to-business sales, exports and rebounding commodity prices, and Bianco sees revenue rising another 6% in 2011.

Nonfinancial companies also are sitting on record cash stashes, which make up 7.4% of corporate assets, the highest figure in five decades. These aren't earning much at the bank, and even after raising dividends to $30 a share in 2011 from $25 this year, and increasing expenditures by 10% to a projected $540 billion next year, S&P 500 companies will still be left with $480 billion in surplus free cash flow, Bianco estimates.

Corporate America learned a lesson during the credit crisis: Don't get caught having to raise money at the wrong time. That's why even cash-rich corporations like Coca-Cola (ticker: KO), Microsoft (MSFT), eBay (EBAY) and Wal-Mart Stores (WMT) have recently rushed to capitalize on the clamor for bonds by issuing debt at minuscule rates—all while they can. "Balance sheets and the ability to issue debt have never been stronger," Bianco says, "and I expect S&P companies to be major recyclers of fixed-income dollars."

That money stockpiled could be steered toward deals, hiring, research and development, or shareholder-friendlier moves.

Goldman Sachs strategist David Kostin expects buybacks to increase 25% to more than $340 billion in 2011, dividends to grow 11% to $270 billion, and companies to plow $240 billion in cash into mergers.

Kostin's 2011 target of 1450 for the S&P 500 makes him the most bullish in our survey, quite a change from his more guarded stance this summer. But improving economic data and forecasts prompted Goldman's economists to nudge up their 2011 U.S. forecast from 1.9% to 2.7%. Today, the cost of money has never been lower, U.S. inflation is low by most measures, and corporate-bond yields have never been lower, Kostin points out. Company balance sheets have never been stronger, and "the path of earnings growth has rarely been smoother."

WILL MAIN STREET SHARE Wall Street's enthusiasm? Stung by two recessions within less than 10 years and a "lost decade" of stock-market returns, many Americans are indifferent to equities. Since the current bull market began on March 9, 2009, the S&P 500 has climbed more than 83%. But during this stretch, investors have pulled nearly $111 billion from U.S. stock mutual funds and plowed more than $609 billion into fixed-income funds. Even those who don't think we're in a bond bubble must wonder if there's a bond-fund bubble.
Confidence Is Slowly Rising, Although Mutual-Fund Cash Is Running Low

Wavering consumer confidence seems to have bottomed and could improve if this government-goosed recovery proves sustainable. Even beleaguered small businesses, which are key to job growth, are starting to feel more optimistic.

But fund managers have been spending their cash. Wall Street needs Main Street to get excited about stocks for this run to continue.
[outlook chart 2]

Will things change in 2011? After the recent Treasury-bond selloff, fixed-income-fund investors receiving their fourth-quarter statements will feel pain for the first time in a long while, especially those convinced that they were moored in a safe harbor. And interest rates are likely to tick higher if the recovery sticks.

"Never in the history of investing has there been an orderly unwinding of the prior leading asset class," says Brian Belski, Oppenheimer's chief investment strategist, pointing to the messy selloffs of, for example, commodities and tech stocks after each peaked. "So why would it be orderly when bonds unwind?"

Lest anyone pegs Belski as a raging stock bull, his 2011 target of 1325 is among the more muted in this group. He was far more bullish in 2009, but has reined in his optimism as the bullish herd swells. He thinks that a secular bull market for stocks can arise –but only after the great unwinding of the bond market. Fortunately for stock investors, he notes, "much of the heavy lifting -- especially by Corporate America -- has already taken place, thanks in part to near-zero interest rates, two recessions, a re-employment cycle that is likely to emerge in the next several months and record high cash balances."

A year ago, the dozen strategists we surveyed had expected the S&P 500 to finish this year at 1239. That's almost a bull's eye, even if they didn't get all their reasoning right. For instance, they predicted, quite correctly, that the U.S. economy would grow slowly and erratically, despite lingering unemployment and plenty of scares along the way. But they also debated how our government would begin to wean our economy from the monetary life support. No one saw a second round of stimulus coming.

Strategists would much rather be contrarians, so the fact that those surveyed this year are in agreement with their peers makes some a little uneasy.

Adding to the anxiety: Our strategists aren't alone in their optimism: A mid-December survey of 302 global money managers showed more institutional investors flocking to bet on cyclical growth and commodity inflation. The horde expecting stronger global growth nearly tripled to 44% from just 15% in October—thank you, Ben Bernanke!—and those expecting better profits jumped to 51% from 11% two months ago.

Another red flag: Cash as a percentage of mutual fund assets—the available ammunition, so to speak—has recently fallen below 30%, and is approaching the depleted levels seen in 2000 and 2006-07. This shrinkage is partly due to the increasing values of stock and bond portfolios; and more than $2.8 trillion still sits in money-market funds. Yet it's also a clear sign that professional money managers are becoming more fully invested, at least in the short term.

But has this bullish consensus become pervasive and extreme? Even as stocks rallied this fall, ordinary investors were yanking money from domestic stock mutual funds and funneling it into bonds or emerging markets.

James Paulsen, Wells Capital Management's chief investment strategist, thinks that most investors still see risks everywhere. "Are people paying too much for houses? Are corporations overstaffed, and are banks lending too much? Look for broad acceptance of a sustainable recovery to take hold first" to signal that risk is rising, he says. Another cue: Wait for our central bank to tilt from policies aimed at easier money to those guarding against an overheating economy.

The lone strategist who doesn't see any upside for stocks in 2011 is Cliggott. The Credit Suisse strategist was surprised by this year's robust profit growth, but doubts it is sustainable.

"This profit cycle in the U.S. has been unusually dependent on the U.S. federal government borrowing enormous sums of money so that they could accelerate government spending and increase transfer payments to both individuals and to states, even as federal tax revenues fell sharply," he argues. "But it's hard to imagine the federal government will keep spending $1.60 for each $1 in tax revenue."

At some point, government spending will need to be cut and taxes raised, which will slow economic and profit growth. "Perhaps it will be a story line in 2012, or 2013–time will tell," notes Cliggott, who expects profit margins to peak in mid-2011.

INFLATION MAY ALSO THICKEN the plot by that time. Loose money policy has already driven crude oil to a two-year peak, and copper last week reached an all-time high. The consumer-price index in the U.S. has risen just 1.1% over the past year, but prices have increased 5.1% in China. When inflation in China–now the world's most-watched growth engine–rises enough to require government restraint to cool off, then watch out.

Michael Ryan, UBS Wealth Management's chief investment strategist, thinks that profits could grow more than expected as corporate cash-hoarding ends, the pace of consumer deleveraging slows, and housing becomes less of a drag on the economy. But he expects geopolitical threats to intensify, and sees the sovereign-debt crisis growing more acute as weak links in the European Union are tested. Next up: Spain, where the cost of insuring against defaults is rising and whose credit rating might get downgraded by Moody's.

"Given Spain's relative importance in the euro zone and Germany's reluctance to underwrite any additional rescue packages, the crisis will shift from concerns over liquidity to fears of solvency," Ryan notes. On this side of the Atlantic, municipalities weakened by declining tax revenues, overextended public services and underfunded pension plans will struggle. "What remains to be seen is whether we'll see a default by a high-profile city big enough to change risk perception," he says.
The Year That Was

View Full Image
outlook timelin
Illustrations: Bobert Neubecker for Barron's; Photographs (left to right): Ed Lallo/Bloomberg News; Kostas Tsironis/Bloomberg; Jewel Samad/AFP/Getty Images
outlook timelin
outlook timelin

Ryan also doubts that the housing market will bounce back, given the 8.6 months it would take to exhaust the backlog of unsold homes, a still-high level of foreclosures and the prevalence of negative housing equity. UBS sees the S&P Case-Shiller home-price index slipping 5% in 2011. But because housing is already depressed, and "price declines are likely to be manageable, continued weakness in residential real estate won't trigger another recession," he predicts.

Morgan Stanley's McVey thinks housing is "the swing factor of economic variables," and interest rates must rise in an orderly fashion for the stock market's valuation multiples to hold. Unless housing is fixed, the S&P 500's profit growth could turn negative by mid-2012. And ultimately, "the Fed and the government have to engineer job and wage growth," he says. "If they don't, the equities-over-bonds trade is just that–a trade."

So where should we invest? Belski sees dividend investing as the bridge from bonds back to equities, and suggests looking for companies best poised to raise payouts.

He screened for S&P 1500 companies with strong free cash flow, a history of dividend hikes in each of the past 10 years, a credit rating of A-minus or better from S&P and a dividend yield comparable to 10-year Treasuries. His list of 18 includes Abbott Laboratories (ABT), Automatic Data Processing (ADP), Bemis (BMS), Genuine Parts (GPC), Illinois Tool Works (ITW), Pitney Bowes (PBI) and apparel-maker VF (VFC).

Goldman's Kostin tracked down 25 heavy-lifters that account for two-thirds of the S&P 500's projected margin growth next year. Ten of these are tech companies, and his list includes Apple (AAPL), Google (GOOG), Oracle (ORCL), Qualcomm (QCOM), ExxonMobil (XOM), Merck (MRK) and Pfizer (PFE).

On the other hand, Kostin also screened for stocks whose projected 2011 margins are uncomfortably high relative to their historical margin peaks. These carry the loftiest expectations—engineering firm Cummins' 2011 margins (CMI), for instance, are 130% that of its previous peak. Others on that list include Cliffs Natural Resources (CLF), MedcoHealth Solutions (MHS), VeriSign (VRSN), Hospira (HSP) and Ford (F).

Putnam's Knight thinks that the starkly divergent policies between countries like China and Brazil that are tightening monetary policy and the U.S. will manifest itself most directly in the currency markets. Diversified portfolios ought to have exposure to the strengthening currencies of the emerging markets as well as Australia, Canada and Scandinavia, he says.

Given their bullish bent heading into 2011, many strategists are tilting toward cyclical sectors that historically thrive as the economy improves. "The noise of the spring and summer only pushed out the recovery," says Belski, "moving the cycle back a few steps only to see fundamentals reignite the cycle again in the fall." His advice: Focus on areas likely to grow with the economy, such as technology, industrials and consumer discretionary.

SOME THOUGHTS on the strategists' sector selection:

• Technology is favored by eight of our strategists and shunned by none. The beloved sector can seem sexy and safe at the same time -- it's hitched to business spending and global growth, holds the allure of improved productivity for cost-conscious employers, and is backed by the deepest pockets. But is it becoming a crowded trade? Many individual investors burnt by the tech bubble are still wary, but when they start coming around, be careful.

• The new pariahs are utilities and health care, which between them amassed 12 disses and just one nod. Contrast these with energy and industrials, each favored by five strategists and avoided by none. The case against rate-sensitive utilities is well understood, and the threat of rising interest rates quite real. But at some point, the collective lunge at growth will get old, and cheap-enough stocks will start attracting attention.

• Given the uncertain pace of the housing-market recovery, banks' exposure to sovereign debt problems, and the fragile state of consumer confidence, most strategists are neutral on the financial and consumer-discretionary sectors. The few who weighed in are split.
Investors Buy Into Economic Recovery

Consumer discretionary and industrial shares topped all other sectors in the S&P 500 as utilities and health care fell out of favor.
Sector         2010*         2009         2008         2007
Energy         13.5%        11.3%        -35.9%        32.4%
Materials         14.9        45.2        -47.1        20.0
Industrials         21.8        17.3        -41.5        9.8
Consumer Disc         24.3        38.8        -34.7        -14.3
Consumer Staples         10.0        11.2        -17.7        11.6
Health Care         0.4        17.1        -24.5        5.4
Financials         7.2        14.8        -57.0        -20.8
Info Technology         8.4        59.9        -43.7        15.5
Telecom Services         10.4        2.6        -33.6        8.5
Utilities         -1.0        6.8        -31.6        15.8
S&P 500         10.8        23.5        -38.5        3.5
*As of 12/15/2010. Source: Standard & Poor's

Consumer-discretionary stocks, a group that includes Nike (NKE) and Priceline.com (PCLN), have rallied 24% this year and are 2010's top performers by far. It's widely—and perhaps correctly—assumed that demand might stay sluggish. What is underappreciated, however, is how rapidly companies are restructuring their supply chains. The competition, those left standing after the credit crunch, also is more rational. In light of these factors, and with so many fence-sitters, a slight improvement in demand could go a long way.

• Consumer staples gained 10% this year, and have gotten a little lost in the latest growth scrum. Raw-material costs are rising, but many of these companies have strong balance sheets. They have an appealing average dividend yield of 2.7%, and rake in enough cash flow to maintain and raise their payouts.

Many of the companies in this group, such as PepsiCo (PEP) and Procter & Gamble (PG), get much of their revenue and profits from fast-growing emerging markets. Says UBS's Ryan: The sector doesn't just have a global footprint, but it has the right one. And that could pay off nicely in 2011.
回复 鲜花 鸡蛋

使用道具 举报

发表于 2010-12-23 04:59 AM | 显示全部楼层
Thanks.
回复 鲜花 鸡蛋

使用道具 举报

发表于 2010-12-24 03:32 PM | 显示全部楼层
Thanks.
Happy a very happy holiday and prosperous 2011!
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2010-12-30 11:07 PM | 显示全部楼层
回复 3# ppteam

Tech Stocks Set To Soar in 2011 as a New Era of Personal Computing Dawns

Technology companies, and tech stocks, started a revival in 2010 and are heading toward an even more profitable 2011. That's because a new age of computing - one that prioritizes mobility and efficiency - has dawned in the computing world.

Indeed, we've entered what researching firm International Data Corporation (IDC) calls a "new era" of computer usage.

Roughly half of all regular Internet users in 2011 will use non-PC devices, according to IDC, which says a trend becomes mainstream when it constitutes more than 15% of the market.

Just as the smaller PCs of the 1980s supplanted the lumbering terminals of the 1960s, PCs are being replaced by a variety of hand-held devices - like Apple Inc.'s (Nasdaq: AAPL) iPhone and iPad and Research in Motion Ltd.'s (Nasdaq: RIMM) Blackberry.

"The PC-centric era is over," IDC said in its annual report, released in November.

The firm predicts 330 million smartphones will be sold worldwide next year along with 42 million media tablets.

"These devices will be increasingly embraced as complements if not substitutes for PCs where voice and light data consumption are desired." Raphael Vasquez, an analyst at tech research firm Gartner Inc. (NYSE: IT), said in a statement.

A slow down in global PC shipments is already hitting manufacturers. Gartner cut its 2011 prediction for PC shipments to a 15.9% rise from 2010, down from the 18.1% increase the firm originally expected.

By mid-2012, non-PC devices are expected to out-ship PCs, Gartner says.

The shift means that PC makers will no longer be able to rely on price slashing to move their products. Instead, they will have to follow consumers into the mobile computing market.

For example, Taiwan-based Acer Inc. - the world's No. 2 PC vendor - is doing just that. To shift from the diminishing PC-only market, Acer last month released its own tablet computers. It aims to nab a 15% - 20% share of the global tablet market next year.

"For Acer, we want to become a significant player as soon as possible," Acer Chairman J.T. Wang said at the Reuters China Investment Summit. "Tablet is a huge market and it shows a new path for new growth."

Of course, Acer isn't the only company adapting to this hot new trend - and knowing which companies are leading the transition will be the key to unlocking profitable technology plays in 2011.

New Products Breed New Competitors
The iPad took the tablet computer mainstream in 2010, and it's likely to keep its spot as the best-selling tablet computer in 2011. But that won't stop companies with lower-cost alternatives - including Dell Inc. (Nasdaq: DELL), Hewlett-Packard Co. (NYSE: HPQ) and Samsung Electronics Co. Ltd. - from taking aim at the tablet's market share in 2011.

Overall tablet sales are expected to more than double next year, according to IDC. And shipments could grow an average of 57.4% per year in 2010-2014 as emerging market demand for the technology heats up.

IDC estimates that IT spending in regions like Latin America, Asia, the Middle East and Africa next year will increase by 10.4% to $440 billion - equal to 27% of total global IT spending.

Worldwide IT spending will grow by 5.7% next year to $1.6 trillion, IDC says.

Tablets won't be the only new technology driving growth, either. Smartphones will play their part.

Apple and Google Inc. (Nasdaq: GOOG) have been the most successful in the smartphone market so far. The success of the iPhone has made Apple the smartphone market leader, but phones running Google's Android software snagged 25% of the market in the third quarter.

Still other tech companies are finding a niche for profit, as well.

Research in Motion's less costly BlackBerry Curve 3G 9330 and Nokia Corp.'s (NYSE ADR: NOK) Nuron smartphone have gained popularity among more frugal consumers.

These more affordable midrange smartphone options cost between $100 and $200 and are the fastest-growing smartphone segment, with sales expected to reach $28 billion in 2014 from $7 billion in 2010. They still offer Internet usage, but lack the camera and video capabilities and downloading speed of their pricier competitors.

In addition to smartphone and tablet manufacturers, mobile application developers stand to profit from the surge in mobile computing, as well.

Application downloads are expected to jump by 60% a year through 2014, producing more than $35 billion. Apple's iStore boasts more than 300,000 apps, and phones using Google's Android platform have access to more than 80,000 apps. Experts see those numbers growing to 750,000 for Apple and 550,000 for Google in 2011.

Cloud Computing Takes Over IT
Mobile computing isn't the only trend that's found its stride in the mainstream.

Cloud computing - web-based storage and network service - was one of the hottest tech buzzwords in 2010. Public clouds are becoming "the dominant technology platform for the next 20 years," said Frank Gens, chief analyst for IDC.

Worldwide spending on public IT cloud services will hit $29 billion next year, a 30% jump from 2010. Furthermore, 80% of new software products will be deployed on cloud platforms. This will push cloud computing to a crucial point in 2011, said IDC's Gens, as it becomes the norm for corporations' IT models.

The rapid growth in cloud computing has already triggered a flurry of mergers and acquisitions (M&A) activity in the data storage market. Hewlett-Packard Co. (NYSE: HPQ) bought 3PAR Inc. in September for $2.35 billion, EMC Corp. (NYSE: EMC) bought Isilon Systems Inc. (Nasdaq: ISLN) in November for $2.25 billion, and Dell Inc. (Nasdaq: DELL) bought Compellent Technologies Inc. (NYSE: CML) earlier this month for $960 million.

With so many smaller companies already snatched up, there are only a few options left for consolidation. Remaining contenders for a 2011 buyout are CommVault Systems Inc. (Nasdaq: CVLT) and Teradata Corp. (NYSE: TDC).

Teradata Corp. is setting up for a good run on cloud computing growth. The data storage company just bought software provider Aprimo to expand its offerings in cloud-based analytics. KeyBanc issued a "buy" rating for the stock and said it should post solid earnings into 2012. It could also catch the eye of larger competitors like H-P, Microsoft Corp. (Nasdaq: MSFT) or Oracle Corp. (Nasdaq: ORCL).

Look for industry heavyweight Dell Inc. to stay on the hunt in 2011 to grow its piece of the cloud computing industry. Its need to invest in M&A to survive the industry shift away from PC-dominance could weigh on its earnings next year.

"We believe Dell, in particular, will need to acquire a significant amount of enterprise technology if it is going to successfully transition from a PC-centric company to an enterprise solutions leader," said Goldman Sachs Group Inc. (NYSE: GS) analyst Bill Shope.

"The Next Microsoft"
Competition to win the public-cloud service platform crown will heat up as other contenders vie for the title of "the next Microsoft," as IDC puts it, establishing a market position similar to Microsoft's dominance with its Windows applications.

Top challengers include Salesforce.com Inc. (NYSE: CRM) and Oracle.

Salesforce.com provides cloud-computing applications and is expanding its cloud offerings in an attempt to snag more of the $21 billion-a-year database market.

Salesforce.com will launch Database.com, a database program designed to manage corporate data and round out the company's cloud services offerings. Now it can charge one fee for software costs, Internet hosting and data storage. That's a different approach than the usual process of requiring businesses to buy and install software before the database companies manage the data.

"It's an alternative delivery method," Gartner analyst David Feinberg told Reuters. "They could very well be on to something."

Some analysts predict Oracle will hit back and make a play to buy Salesforce.com next year. Oracle wants Salesforce.com's CRM clients, and Salesforce.com would benefit from Oracle's global client network.

Many analysts are looking for a hot 2011 performance from Oracle and have issued "buy" ratings on the stock with price targets around $34. Oracle is currently trading around $31 and is up 29% so far this year.

Crowded Internet Creates Rise of CDNs
The phenomenal growth in online reliance with mobile and cloud computing is shifting the Internet infrastructure by changing what is needed from a network provider - and giving some much-deserved attention to a little known industry.

Mobile and cloud users will push online activity farther than it was designed to go, streaming videos and downloading files bigger and more frequently than ever before. Networking specialist Cisco Systems Inc. (Nasdaq: CSCO) estimates Internet traffic will quadruple by 2014 and 90% of it will be online video, gaming and mobile services. Netflix Inc. (Nasdaq: NFLX) alone accounts for 20% of all Internet traffic on a given evening, according to network solutions provider Sandvine Corp.

Indeed, content providers will need help from content delivery networks (CDNs).

While mobile devices and cloud computing have already gone mainstream, CDNs are in line to be next year's biggest growth trend. Companies like Netflix and Amazon.com Inc. (Nasdaq: AMZN) will stream an increasing amount of applications over the Internet, requiring more bandwidth and creating a larger market for CDNs.

The big three so far in this industry are Level 3 Communications Inc. (Nasdaq: LVLT), Akamai Technologies Inc. (Nasdaq: AKAM) and Limelight Networks Inc. (Nasdaq: LLNW). They've all positioned themselves to boom next year and companies want to ensure smooth streaming for their customers. All three have partnered with Netflix to stream its content.

IDC expects CDNs increased value in 2011 to bring some M&A activity in the industry, with network operators and IT services companies going after independent CDNs. Companies also are likely to start developing in-house CDNs.

Profiting After the PC
There are a few different approaches investors can take to profit from tech sector growth, including plays in Internet-related exchange-traded funds (ETFs) that will rise as the industry strengthens in 2011.

The First Trust Dow Jones Internet Index Fund (NYSE: FDN) includes a broad range of companies generating revenue from the Internet. Its holdings are concentrated in Google, Amazon.com, and eBay Inc. (Nasdaq: EBAY). It also holds shares in network infrastructure company Juniper Networks Inc. (NYSE: JNPR) Salesforce.com and Netflix. It's up around 32% so far this year.

The Technology Select Sector SPDR ETF (NYSE: XLK) offers a more technical approach by investing in companies focused on hardware, software and networking. Apple makes up 12% of its assets, with other big names including International Business Machines Corp. (NYSE: IBM), Cisco, and Oracle.

Finally there's the PowerShares QQQ Trust ETF (Nasdaq: QQQQ), which mirrors the Nasdaq's performance and is up more than 19% this year. It has almost 20% of its assets in Apple, and also holds Google and Research in Motion stock.

For individual stocks, confident moves and innovative products will lift competitors ahead of rivals.

Investors wanting to go "to the cloud" for profits in 2011will have a lot of options. In addition to Salesforce.com and Oracle, data storage leader EMC Corp. (NYSE: EMC) has been getting a lot of attention.

Goldman's Shope issued a "buy" rating earlier this month for EMC with a price target of $27. Shares have been on a steady upward climb for two years now and are up almost 30% in 2010.

EMC is cheaper than its data storage competitors at around $22 a share. Rival NetApp Inc. (Nasdaq: NTAP) is trading around $53, and the much larger Hewlett-Packard is around $41.

EMC also holds an 80% stake in virtualization specialist VMware Inc. (NYSE: VMW) meaning it'll benefit nicely from growth in its specialty of virtualization. Virtualized operating systems are the building blocks of cloud computing.

While there are many up-and-coming tech leaders on the horizon, those who want to go with a consummate industry professional should turn to Apple.

Experts continue to tout Apple as a portfolio winner. A successful 2010 allowed the company to sink its teeth into the top spots of the smartphone and tablet markets. And now it's working on improving its top sellers to ensure its rivals' models don't get far in their attempt to steal the tech gadget crown.

"Pretty much everything is going right for Apple at this point and the stock actually looks cheap," Jason McPharlin, portfolio manager at Northstar Capital Management, told CNNMoney.

Analysts are expecting a 26% profit increase in Apple's fiscal year 2011. It plans to roll out a Verizon-capable iPhone after the New Year, which could give it back some smartphone ground it lost to Verizon users who went with products running Google's Android operating system.

"Apple is the single most attractive growth stock I know. There's Apple and there's everyone else," said Jon Burnham, manager of the Burnham Fund.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2010-12-30 11:09 PM | 显示全部楼层
回复 6# ppteam


Biotech Stocks Will be Fueled by Takeovers in 2011

While a number of companies are on the verge of hitting the market with exciting new drug products or medical treatments, the biggest 2011 profits for investors in the biotech stocks are more likely to come from mergers and acquisitions  (M&A) than research and development (R&D).

That's because mergers and buyouts in the industry have far outpaced the sector's overall growth rate, which in recent years has been sluggish. Indeed, IMS Health, a leading research and analytical firm serving the pharmaceutical and medical industries, projects only a slight increase in worldwide growth in 2011 - 5% to 7% versus a pace of 4% to 5% this year - with a similarly restrained outlook stretching out to 2015.

By contrast, virtually every major player in pharmaceuticals worked at least one M&A deal in 2010. That trend is expected to continue, if not accelerate, in the years ahead as drug companies look to broaden product lines, replace revenues lost to patent expiration and expand into emerging markets, where the industry growth rate is much higher in than in the developed nations.

It's also much more economical for big companies to acquire potential new "blockbuster" drugs - those with an annual market potential of $1 billion or more - by buying smaller specialized firms with products already well along in the development "pipeline" than it is to fund the prolonged research, testing and approval process from scratch. A few examples of recent major buyouts include:

    * Johnson & Johnson's (NYSE: JNJ) buyout of California-based medical-devices maker Micrus Endovascular Corp.; its agreement to acquire all rights to Elan Corporation's (NYSE: ELN) Alzheimer's Immunotherapy Program (AIP); and its September announcement of intent to complete acquisition of Crucell NV, a Dutch firm  specializing in the discovery, manufacture and commercialization of vaccines.
    * Pfizer Inc.'s (NYSE: PFE) announced acquisition of King Pharmaceuticals Inc. (NYSE: KG) in order to boost its position in the pain-management market.
    * Bristol-Myers Squibb Co.'s (NYSE: BMY) $2.4 billion buyout of Medarex Inc., a specialist in manufacture of antibody-based drugs, in a bid to broaden its research into treatments for cancer and immunologic conditions such as arthritis, lupus and psoriasis.
    * Abbott Laboratories' (NYSE: ABT) April acquisition of Facet Biotech Corp., a developer of drugs to treat various types of cancer, including chronic lymphocytic leukemia.


The biotech industry is actually much broader than just drugs, therapeutics and medical devices. It also encompasses companies engaged in biological research of technologies for agriculture, bio-fuels and even environmental protection. As an example, Bayer AG (PINK: BAYRY), best known for its aspirin products, actually gets a major stream of revenue from its Crop Sciences Division.

However, pharmaceuticals and medicine dominate the biotech industry - and they are the source of many of the obstacles to strong future growth. Notable challenges include:

    * A number of significant patent expirations, allowing for increased competition from generic drugs. In 2011 alone, pharmaceutical products generating annual sales of more than $30 billion will lose their patent protection. This includes drugs such as Lipitor, Plavix, Zyprexa and Levaquin, which together accounted for more than 93 million 2010 prescriptions in the United States alone.

Still more drugs will lose patent protection in 2012 - and, by 2015, prescription medicines that currently generate annual sales of $142 billion will face generic competition. In spite of the wave of mergers and acquisitions, it's unlikely the industry can bring new products to market that will generate anywhere near the same level of revenue - especially in the blockbuster category, which saw just 14 new entries in 2009, generating combined sales of $50.7 billion. IMS Health sees a further decline in this area, with approval and launch of just five new blockbuster products expected in 2011.

    * A shift in growth patterns in world markets. A significant portion of the 5% to 7% growth expected in 2011 will come from the 17 countries the industry refers to as "pharmerging markets" - countries like China, India, South Korea, Indonesia, Brazil, etc. Sales growth of 15% is forecast in those markets, many of which are benefitting from increased government spending on healthcare and broader private health coverage for workers. Total sales of up to $180 billion are projected, with $50 million of that coming from China alone, where the growth rate is expected to exceed 25%.

By contrast, growth of just 1% to 3% is forecast for the major European markets and Canada, with 3% to 5% growth predicted in the United States, which is still the world's largest drug consumer with 2011 sales expected to hit $320-$330 billion, up from $310 billion this year.

    * A tougher regulatory environment in the developed countries. The U.S. Food & Drug Administration and many foreign regulatory bodies are becoming more reluctant to grant initial approval for new drugs in the face of numerous recalls and growing safety concerns among the public.
    * Pressure from governments and private insurers to reduce medical and drug costs. Governments in virtually all of the developed countries are pushing cost-cutting measures, including increased use of generic medications, mandatory price cuts for brand-name drugs and elimination of rebates. Private insurers are increasing requirements for pre-authorization of treatments and higher cost-sharing percentages for patients.
    * Shifting government attitudes are also reflected in a reduction of research funding. The New York Times recently reported that the change in power in Congress in the wake of the November elections could result in a 12.3% reduction in President Obama's requested budget of $65.9 billion for non-military medical research and development. Those cuts would reportedly take $2.9 billion from the National Institutes for Health (NIH) and more than $1 billion from the National Science Foundation (NSF).   
    * An increase in demand for specialty drugs and medical products to meet the needs of smaller patient groups, such as those with so-called "orphan" diseases. Such drugs, while often approved by regulators on a fast-track basis, typically have high development costs relative to projected revenues.
    * Rapid growth in demand due to the unmet needs of an aging population. While this represents opportunity and large potential profits for biotech and pharmaceutical companies, it also puts a strain on development budgets and requires reallocation of resources. For example, everything from manufacturing space to marketing budgets may need to be redirected from products where low-cost generics are available to new therapies where patent protection can be maintained.

URCH Publishing, a specialty healthcare publisher, identified six major classes of biomedical research in a recently released report, Pharmaceutical Market Trends, 2010-2014. They are alimentary/metabolism, antineoplastic/immunomodulatory, anti-infectives, central nervous system (CNS) biomarkers, cardiovascular systems and respiratory systems.

I'm not going to waste your time trying to define each class in detail. Rather, I'll just note that key therapies on which many biotech companies are currently focusing include stroke prevention and treatments for various heart conditions, melanoma, multiple sclerosis, breast cancer and hepatitis C. Vaccines for several types of cancer, HIV and other diseases are also being researched, as are numerous therapies using both embryonic and adult stem cells for regenerative treatment of spinal energies, eye diseases such as age-related macular degeneration (which afflicts more than 30 million worldwide) and other degenerative diseases.

From an investment standpoint, the companies doing this innovative and potentially game-changing biotech research offer tremendous opportunity. If a therapy makes it to market and gains medical acceptance, it could join the ranks of the 125 pharmaceutical products that generated more than $1 billion in global sales in 2009, sending the company's stock through the roof.

As an example, the stock of a company called Dendreon Corp. (DNDN) traded for years in a range of $3 to $8 a share with very little activity. Dendreon discovered a prostate cancer vaccine (named Provenge) that "trains" the body's immune system to destroy tumors, but it had a long battle getting FDA approval. Finally, in early 2009, DNDN got the okay to sell the drug, which is expected to have sales of $4.3 billion by 2020. In just 10 days, the stock more than quadrupled to $22 - and it peaked at $57.67 on May 3. It subsequently pulled back with the rest of the market, but still stands above $38 today.

That clearly illustrates the potential in biotech, but the risks are also quite high. Many of the smaller medical R&D companies - and there are literally hundreds of them in the United States alone - are focused on a single therapy, whether a drug or other type of treatment, or on a single disease. If the therapy fails, or the company runs out of money before testing can be completed, the stock can go bust in a matter of days. And, even if it finds funding, the arduous testing and approval process can drag on for a decade or more, with the stock often languishing at prices under a dime.

That's why it only makes sense to focus on the stocks of companies that have established products in addition to those in the developmental stage, giving them a solid revenue stream to finance research. Look for companies that show quality, but are still on the cutting edge of technology.

If you prefer to try for a home run with a firm still doing tightly focused research or having only a single product, stick with one whose drug or therapy is well along in the development pipeline. That puts it within sight of regulatory approval - or, quicker and potentially more rewarding, makes it a takeover target for one of the pharmaceutical giants. Plus, even if such companies don't get bought out, they're still ripe for usually lucrative licensing agreements with leading distributors.

That's what happened with many of the best biotech investments of the past - and it helps explain how big pharma's Top 10 companies got control of the products needed to roll up total sales of $317 billion in 2009.

Three stocks currently worth considering based on these criteria are:   

Gilead Sciences, Inc. (Nasdaq: GILD), recent price $36.83 - GILD has almost a dozen products, including Truvada, which helps prevent the spread of HIV among those already infected, and a treatment for hepatitis B, a major seller in Asian markets, where the disease is widespread. Gilead has marketing partners or sales units in Europe, Asia, the Middle East, Australia and Latin America, and has consistently topped revenue projections in recent quarters. Earnings per share were $3.41 for the past 12 months, and the P/E ratio of 10.80 is below industry averages.

Neurocrine Biosciences Inc. (Nasdaq: NBIX), recent price $7.90 - NBIX concentrates on neurological and endocrine-related diseases and has eight products in various phases of development and testing. The company has just begun generating revenues from two of its therapies, including one for Type II diabetes, America's No. 1 growth disease. Revenue of $32.9 million is expected for 2010, with growth to $68.8 million, and NBIX posted its first-ever profit of $3.33 a share in the third quarter. What makes it most interesting, however, are its "pipeline partnerships" with Abbott Labs in men's and women's health, GlaxoSmithKine (NYSE: GSK) in anxiety and depression treatment, and Boehringer Ingelheim Chemicals for diabetes - assuring NBIX of needed funding and ample future marketing help.

Cepheid Corp. (Nasdaq: CPHD), recent price $22.70 - A non-drug biotech entry, CPHD makes molecular diagnostics systems for use in gene therapy and DNA analysis. Primary markets are hospitals, emergency rooms and laboratories, though the company's GeneXpert System is also being used by security agencies charged with identifying bio-threats. The company is still operating in the red, but revenues have risen and losses declined for the past two years, and a profit is projected for the first quarter of 2011.
If you go looking for other small companies in biotech, you'll find a wide range with stock prices under $5.00. Many of these have strong potential, but diversification is a must. The best approach is to split your money among a minimum of four low-priced specialty biotech stocks. That way, you can watch three go bust and still come out well ahead if one of them makes good - or gets bought out.

As an alternative, you can get instant biotech diversification by purchasing shares in one or more of the five exchange-traded funds (ETFs) that now focus on the industry. Two of the leading ones are:

SPDR S&P Biotech Fund (NYSE: XBI), recent price $61.25 - This fund attempts to mirror the performance of the S&P Biotechnology Select Industry Index, holding shares of 28 stocks making up that index. It has the lowest expense ratio in its class at just 0.35% and has traded over a range of $47.01 to $62.11 the past year.

iShares Nasdaq Biotechnology Index Fund (Nasdaq: IBB), recent price $90.58 - The most broadly diversified of the current biotech ETFs, IBB holds shares of 126 different companies comprising the Nasdaq Biotechnology Index, though it does not precisely mirror the index at all times. The expense ratio is 0.48% and the trading range over the past year has been $70.00 to $93.53.
回复 鲜花 鸡蛋

使用道具 举报

发表于 2010-12-31 11:34 AM | 显示全部楼层
回复 鲜花 鸡蛋

使用道具 举报

发表于 2011-1-2 08:08 AM | 显示全部楼层
谢谢
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:11 PM | 显示全部楼层
回复 7# ppteam

Dow to hit all-time year next year? Odds look good


The stock market's strong finish in 2010 has the momentum of history behind it and could push share prices to record highs in 2011, according to Jeffrey Hirsch, editor-in-chief of Stock Traders Almanac.

In an analysis of market peaks and valleys over election cycles dating back to 1914, Mr. Hirsch found that the Dow Jones Industrial Average tends to gain about 50% from a low in the midterm election year to a peak the following year.

Applying that pattern to the Dow's July 10 low of 9,686 means investors could expect a 2011 peak of more than 14,450, which is nearly 25% above where the index is currently trading.

It would be a new high for the Dow, surpassing the mark set in October 2007.

“We'll get a better reading on this once we see how the new Congress works with the president,” Mr. Hirsch said. “Timing and level-wise, the midterm rally is under way, but there are still some things lurking like high unemployment, credit and housing issues.”

The Dow gained more than 5% in December, is up 7.4% from the start of the fourth quarter, and has gained nearly 20% from the July low point.

Mr. Hirsch admits the analysis factors in the historic pattern of the third year of a presidential term, which hasn't seen a negative stock market since the 2.9% decline in 1939.

Of the 24 midterm market rallies between 1914 and 2007, the biggest gain was 89.6% in 1915, followed by an 81.2% gain in 1987, and a 73.6% gain in 1935.

The smallest midterm market advance was a 14.5% gain in 1947 during the industrial construction after World War II.

Mr. Hirsch's research found that the next four smallest market rallies also coincided with significant geopolitical and economic challenges.

In 1979, during an economic downturn and the Iranian hostage crisis, the midterm rally was 21%.

In the midst of the economic collapse in 1931, the Dow's midterm rally was 23.4%.

During the Vietnam War in 1967, the Dow's rally was 26.7%.

And, during the period ending Oct. 9, 2007, with the country in two wars, the Dow reached its all-time high of 14,164 for a midterm rally of 32.8%.

Dating all the way back to Andrew Jackson in 1833, the Dow has seen an average one-year gain of 10.5% during the third year.

Over that 177-year period, which has included 44 third-year markets, the Dow was positive 33 times and negative 11 times for a total gain of 464%.

The biggest return was 81.7% in 1915, during the third year of Woodrow Wilson's first term.

The Dow gained 30.5% in 1919, during the third year of President Wilson's second term.

The worst third-year performance was in 1931, when the market lost 52.7% under Herbert Hoover.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:13 PM | 显示全部楼层
回复 10# ppteam

2011 Predictions

2011 Predictions are widespread and vary from the health of the economy, to changes in political policies and even outcomes of major sports events.

According to Lookout on Yahoo News, the top five 2011 predictions are:   

• The stock market will continue to make gains, consumer spending will pick up, and corporate profits will remain on the rise. But unemployment won't come down much, and inequality will keep growing.
• Someone, somewhere in the United States, will face criminal fraud charges in connection with the foreclosure mess.
• Rightly or wrongly, Julian Assange won't be convicted of a crime, whether in connection to the WikiLeaks disclosures or to allegations of sexual assault in Sweden.
• Conservatives will label EPA administrator Lisa Jackson a socialist, as the agency steps up efforts to regulate carbon dioxide.
• The challenge to President Obama's healthcare overhaul will come before the Supreme Court. By a 5-4 vote, the law's constitutionality will be upheld, with Justice Kennedy siding with the court's four liberal justices in the majority
The Financial Times predicts that when it comes to the economy, the Euro will survive, China will remain strong, WikiLeaks will face competition from ‘copy cats’ and “not to celebrate just yet”- the dark days aren’t over. House prices in the U.S. are predicted to continue to fall.

Reuters's Felix Salmon said “I wouldn't be at all surprised to see the US homeownership rate fall a lot in coming years, back down below even its long-term mean around 64%. And if that happens, prices—both to rent and to buy--are almost certain to fall from current levels.”

Weighing in for 2011 sports predictions are the Bleacher Report and Andy Glockner of Sports Illustrated.

Glockner believes that neither the Duke’s men’s team nor UConn’s women’s team will win the national title in college basketball. The Bleacher Report predicts that Terrelle Pryor will enter the 2011 draft and that Michael Vick will return as the Philadelphia Eagles’ quarterback.

And one of the biggest predictions for 2011 is a prediction for 2012- will Sarah Palin run as a presidential candidate?
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:15 PM | 显示全部楼层
回复 11# ppteam

Things I Refuse to Worry about in 2011

I began worrying in 1995. I had two jobs: my fulltime job at HBO during the day and by night I was starting a company which built websites for other companies. In the summer of 1995 I would work all day at HBO and then at night was building americanexpress.com and Toshiba.com. I had deadlines everywhere and on the other side of those deadlines were very serious people who had stern bosses and their own deadlines. And it was my first experience dealing with clients, technologies across multiple platforms, people with real world deadlines. It was ugly and scary.

I felt the worry in my body. Whereas just a few weeks earlier, if it was 7pm at night there was a guarantee that I would’ve been at Steinway Billiards in Astoria playing backgammon, hanging out with friends, playing chess, drinking coffee, laughing, that all stopped once I started doing these mega-websites. My stomach began to clench. I feel it right now as I’m writing this. It’s a fear that finds itself right at home in my gut and it refuses to leave. I invited it in in 1995, and it dusted everything else, built a bookshelf, kicked up its legs, starting sipping a cognac, and has never left since. Its an unwelcome guest but it won’t leave. Do you know what I mean?

Since then I’ve worried about many many things. I can’t list them all but I’ll just tell you on my first business here is a small list: worried about getting clients, worried about keeping them happy (particularly when they were unhappy), worried about finding good employees, worried about keeping them happy when the work was boring or hard or late at night, worried about why employee XYZ was crying, worried about making payroll, worried about when Steve, the client, wouldn’t pay his bills. Worried about when one client went out of business and stopped paying. Worried about HBO finding out I was running a business on the side. Worried about finding an offer for the business. Worried about when the offer was made that they would later back out (a typical boyfriend-girlfriend worry). Worried about keeping them happy once they bought the business so they wouldn’t sue me. Worried the landlord wouldn’t demand payment when he had to approve the new lease-owner right before the sale of the business closed. Worried no employee would get sick when we forgot to pay insurance. This is maybe 1/10 the worries on that first business. And that was 1995-1998. I’ve had numerous parters, businesses, clients, employees, relationships since then. I’ve started new businesses. I’ve started new careers. All with worries. Oh, and then having kids automatically magnifies those worries.

Ugh. Writing this makes me sick. On Christmas day, no less. Then, of course, there’s the macro worries. Worries about the economy, about unemployment. Worries about terrorist war, or global warming (which is a luxury worry – you only worry about thatn when you are gainfully employed and can put food on the table). Worries about the stocks that I own.

One time I was buying an apartment in 1999. It was right next to the World Trade Center. Two blocks away off of Church Street. I asked the real estate agent,  Nancy, “what if terrorists blow up the World Trade Center?” My main concern of course, if that were to happen, was that the value of my property would go down. Nancy laughed and said, “you can’t live your life that way.”  But sometimes you should live your life that way.

Here’s some of the things I am not going to worry about in 2011.

-          Obama. Everyone was worried. Conservatives were worried he was a Muslim and was going to raise taxes. Liberals were worried he was going to move to the center and ruin their agenda. Whatever. Its all done now. He’s got no agenda either way in 2011. He kept the Bush tax cuts. He kept unemployment benefits. Healthcare may or may not go through legally. There’s literally zero agenda for the man in 2011. So I’m not going ot think about it until 2012. Ditto for the tea party. Who cares about them anymore? There’s no agenda. We spent the money they didn’t want us to spend. Its all over.

-          Global warming. You have to go to China, India, and all the developing countries to express this worry  because that’s where 99% of the pollution is.  But they won’t listen to you. Their people are starving so they need to develop industry to feed them. That causes the CO2 in the air that everyone is worried about. But I’m not worried about it. Lets feed people first.

-         Bookstores and broadcast TV. They are both walking dead. I can’t be sad anytime I’m in a bookstore anymore and there’s less books in their inventory. Its over. Same with broadcast TV. No more soap operas and late night shows. The Internet has slain the beast.

-          Unemployment. This is only going to get better in 2011. How do I know? Because “number of temp workers” and “weekly hours worked” and “average hourly pay” are all at their alltime peaks. Think about it. The only thing to do now is hire people fulltime. Unemployment will go down in 2011. If people even want to work. Unemployment benefits keep getting extended so there is a part of the population that won’t want to work (they are getting unemployment plus any underground economy benefits they accrue). Guess the unemployment rate among college educated people? 4%. Not so bad. And more people are starting businesses than ever. Thats only a good thing.

-          Europe. Whatever happened to Greece? It was in the news every day in March. Now…nothing. Where is it even? Guess how much Greece + Ireland + Portugal equal up to as a percentage of GDP in the European Union. 7%. That’s smaller than New York’s effect on the US GDP. I’m not worried anymore.

-          Inflation. The tea party keeps saying “We can’t keep printing up money. The US is turning into Zimbabwe.” I have news for you. We aren’t Zimbabwe. And where’s all the money? I’m not seeing it. I want to see it. Let there be a little inflation. It would be nice if housing prices went back up. If stocks and company values went up. If wages and employment went up (all byproducts of inflation). We haven’t seen that yet. I’m not going to worry about inflation until I see the benefits of reflation.

-          The stock market. Stocks haven’t even begun to move up yet. We’re only back to where we were at the peak of the Financial Crisis. There’s a whole lot of innovation that hasn’t yet crept into the markets. Once it does its off to the races.

I’m guest-blogging a little bit on CNBC.com this next week. I’ll elaborate more on these and other worries there.

Suffice to say, I’m not worried about the macro stuff anymore. Which leaves me plenty of time to share my personal worries and angst right here on this blog.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:17 PM | 显示全部楼层
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:18 PM | 显示全部楼层
回复 13# ppteam

Ten Economic Questions for 2011

Just some questions looking forward to next year:

1) House Prices: How much further will house prices fall on the national repeat sales indexes (Case-Shiller, CoreLogic)? Will house prices bottom in 2011?

2) Residential Investment: It appears residential investment (RI) bottomed in 2010, and will probably make a positive contribution to GDP growth in 2011 for the first time since 2005. RI is mostly investment in new single family structures, multifamily structures, home improvement and commissions on existing home sales. Historically RI has been the best leading indicator for the economy, but the growth in RI will probably be modest because of the large overhang of excess housing units. How much will RI grow in 2011?

3) Distressed house sales: Foreclosure activity is very high, although activity has slowed recently - probably because of "foreclosure gate" issues. The number of REOs (Real Estate Owned by lenders) is increasing again, although still below the levels of late 2008. How much will foreclosure activity pick up in 2011? Will the number of REOs peak in 2011 and start to decline?

4) Economic growth: After I took the "over" for 2011 back in November, a number of analysts have upgraded their forecasts. As an example, Goldman Sachs noted Friday:

    The US economic outlook for 2011 has improved further with enactment of the fiscal compromise, as well as a stronger trend in recent data. As we forewarned, we are revising up our forecasts to incorporate this news and now expect real GDP to rise 3.4% in 2011 and 3.8% in 2012 (up from 2.7% and 3.6%) ...

It does appear GDP growth will increase in 2011, although GDP growth will probably still be sluggish relative to the slack in the system. How much will the economy grow in 2011?

5) Employment: The U.S. economy added about 87 thousands payroll jobs per month in 2010 through November. This was extremely weak payroll growth for a recovery. How many payroll jobs will be added in 2011?

6) Unemployment Rate: The post-Depression record for consecutive months with the unemployment rate above 9% was 19 months in the early '80s. That record will be broken this month, and it is very possible that the unemployment rate will still be above 9% in December 2011. This high level of unemployment - and the number of long term unemployed - is an economic tragedy. The economy probably needs to add around 125 thousand payroll jobs per month just to keep the unemployment rate from rising (payroll jobs and unemployment rate come from two different surveys, so there is no perfect relationship, and the rate also depends on the participation rate). What will the unemployment rate be in December 2011?

7) State and Local Governments: How much of a drag will state and local budget problems have on economic growth and employment? Will there be any significant muni defaults?

8) Europe and the Euro: What will happen in Europe? When will the next blowup happen? How much of a drag will the problems in Europe have on U.S. growth?

9) Inflation: With all the slack in the system, will the U.S. inflation rate stay below target? Will there be any spillover from rising inflation rates in China and elsewhere?

10) Monetary Policy: Will the Fed expand QE2 (probably not)? Will the Fed reverse any of the Large Scale Asset Purchases? Probably not. Will the Fed raise the Fed Funds rate? Very unlikely.

OK, some of the questions were really multiple questions - and I ventured a guess on the last one.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:19 PM | 显示全部楼层
回复 14# ppteam

Standard & Poor’s: If History Holds, Market Will Rise Next Month

S&P’s Chief Investment Strategist Sam Stovall took a look at the market’s historical performance and divined that the odds favor bullish investors going into next month.

Stovall evokes historical precedent, and a few tea leaves, to make his case:

    * Since 1945, the market has performed better in January than it has in the full year, rising 1.1% versus 0.7%.
    * During a president’s third year in office, the markets have risen 4.3% in January on average, and have risen 95% of the time since World War II.
    * In years ending with a 1, the market tends to rise about 1.2%, versus 6.8% for all years.

“If history should repeat itself once again, and there’s no guarantee it will, the market should have another favorable showing in January of 2011, as well as the first quarter, with the cyclical sectors once again outpacing the defensive ones,” he wrote.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:25 PM | 显示全部楼层
回复 15# ppteam

Fade overbought conditions at your own peril in December


Barring a decline of 1.2% today, the S&P 500 will have traded in overbought territory (>1 standard deviation above its 50-day moving average) for the entire month of December.  Going back to 1928, there have only been seven other Decembers where the S&P 500 (or its earlier iterations) finished every day of the month in overbought territory.  The last time this occurred was back in December 1990.  In the table below, we highlight each of those months as well as the index's performance going forward.  As shown, extended periods of overbought levels haven't necessarily been such a bad thing.  Of the seven occurrences, there were only two periods where the S&P 500 saw declines in the following January.

Overall, this December would be the 71st time that the S&P 500 closed at overbought levels in every day of a given month.  Interestingly, while one would expect a reversion to the mean following these overbought periods, the opposite tends to occur.  In the month after these periods, the S&P 500 averages a gain of 1.52% with positive returns 67.6% of the time.  This is considerably better than the 0.58% average S&P 500 return for all months.

回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:27 PM | 显示全部楼层
回复 16# ppteam

The S&P 500′s Price/Earnings Ratio


Although the market has had a strong run over the past 21 months, the S&P 500 doesn’t appear to be overpriced according to the market’s P/E Ratio.

For 2008, the market earned just $48.51. Last year, earnings climbed to $56.86. This year, earnings are projected to be $83.68. Earnings for next year are projected to be $94.76.

Here’s a look at the S&P 500 (black line, left scale) along with its trailing operating earnings (gold line, right scale). The two lines are scaled at a ratio of 16 to 1 which means that when the lines cross, the P/E Ratio is exactly 16.

回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:29 PM | 显示全部楼层
回复 17# ppteam

Short Interest Declines to Lowest Levels Since 2007


Short interest levels for the middle of December were released yesterday and showed that short sellers haven't been this gun shy since 2007.  The chart below shows the average short interest as a percentage of float (SIPF) for stocks in the S&P 500.  At a current level of 4.15%, the average SIPF hasn't been this low since December 2007.  

While the decline in short interest levels is indicative of the market returning to its more normal footing from the chaos of the credit crisis, the question that bulls need to answer is that with an increasing number of short sellers moving to the sidelines, or even the bullish side, is there anyone left to convince?

回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:29 PM | 显示全部楼层
回复 18# ppteam

Why Investor Optimism May Be a Red Flag


NOW that the market has risen, investors are becoming optimistic again about stocks.

There are many signs of this. The American Association of Individual Investors, for example, reports that most investors now describe themselves as bullish, versus just 20 percent in July.

And the flood of money that was pouring into bond funds largely out of fear, has slowed to a trickle. After pulling in more than $1 trillion in net investments since the start of 2001, bond funds experienced slight net redemptions from the start of November to the middle of December, according to the Investment Company Institute.

All of this suggests that investors are finally getting their risk appetites back. And it may also be an indication that people are becoming greedy after the easy money has already been made in the market.

It’s worth remembering that even though a strong year-end surge has pushed the Standard & Poor’s 500-stock index up 20 percent since the start of September, it’s just part of a tremendous rally over the past two years.

Since the bull market began in March 2009, the S.& P. 500 has climbed more than 86 percent. And investments that are considered riskier than blue-chip domestic stocks — such as emerging-market equities or shares of fast-growing but volatile small companies — have done even better during this stretch. Both the Russell 2000 small-stock index and the Morgan Stanley Capital International Emerging Market index have gained 130 percent.

“We were told that this was supposed to be a ‘new normal’ era where investors should expect lower returns and shouldn’t take much risk as a result,” says James W. Paulsen, chief investment strategist at Wells Capital Management. “But the performance of risk assets over the past 18 months shows that this was anything but a new normal.”

Risk-taking hasn’t been rewarded over just the last 18 months. Despite all the talk about what a “lost decade” this has been for investors, risky asset classes have actually produced sizable gains over the last 10 years. For instance, though the average fund that invests in large-capitalization domestic stocks gained just 1.5 percent, annualized, in that period, small-stock funds returned nearly 7 percent a year. And emerging-market stock funds returned nearly 15 percent, annualized, during that stretch, according to Morningstar.

Risk-taking was also well rewarded in the fixed-income markets. While safe government bond funds gained 4.8 percent, on average, for the past decade, slightly riskier investment-grade corporate bond funds gained 5.4 percent, annualized, and high-yield bond funds — even riskier — returned nearly 7 percent a year.

In general, the more risk you took in asset allocation, the greater your relative performance over the past decade, says Jeffrey N. Kleintop, chief market strategist at LPL Financial.

But that can’t go on forever. Sam Stovall, chief investment strategist at S.& P., looked at how bull markets have unfolded historically since 1949. He found that while the S.& P. has soared 35 percent, on average, in the first 12 months of a new rally, those gains have slowed to an average of 17 percent in the second year of a bull market and just 5 percent in the third year.

Of course, it’s not just investor sentiment that has propelled the market. In a recent strategy report, Brian G. Belski, chief investment strategist at Oppenheimer, notes that strong corporate earnings results and decent news concerning the global economic recovery have contributed, too.

But Mr. Belski adds that these developments have already been priced into stocks. As a result, he worries that the current level of investor bullishness might not be justified.

He points out that during 2010, when he was predicting a strong year for stocks, many investors were skeptical. “Our recent client conversations have taken the proverbial 180,” he wrote. “We now find ourselves defending a less optimistic 2011 market outlook.”

INDEED, some market strategists worry that investor optimism itself may be a headwind to another strong year for the market. Consider how stocks performed in other recent periods of optimism. In October 2007, a survey by the American Association of Individual Investors found that 55 percent of investors were bullish; in the 12 months that followed, the S.& P. 500 fell 37 percent. Similarly, in March 2000, investor bullishness reached 66 percent. And a year after the fact, stocks were down 25 percent.

It just goes to show that by the time the market thoroughly convinces investors to be optimistic, most of the good news is already behind us.
回复 鲜花 鸡蛋

使用道具 举报

 楼主| 发表于 2011-1-2 05:31 PM | 显示全部楼层
回复 19# ppteam

Sentiment Overview: Week Of December 31st 2010


http://tradersnarrative.wordpres ... december-31st-2010/
回复 鲜花 鸡蛋

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

手机版|小黑屋|www.hutong9.net

GMT-5, 2025-2-26 10:30 AM , Processed in 0.091862 second(s), 16 queries .

Powered by Discuz! X3.5

© 2001-2024 Discuz! Team.

快速回复 返回顶部 返回列表